BioCentury | May 25, 2017
Finance

Europe’s translational springtime

European science is showing early signs of translational growth, with VCs increasingly shifting their focus to preclinical assets. But investors are concerned the region still doesn’t have the supply of management talent or funding it...
BioCentury | Oct 17, 2016
Financial News

UGISense completes venture financing

UGISense AG , Munich, Germany Business: Genomics Date completed: 2016-10-12 Type: Venture financing Raised: EUR1.2 million ($1.3 million) Investors: Lead Discovery Center GmbH ; private investors WIR Staff...
Items per page:
1 - 2 of 2
BioCentury | May 25, 2017
Finance

Europe’s translational springtime

European science is showing early signs of translational growth, with VCs increasingly shifting their focus to preclinical assets. But investors are concerned the region still doesn’t have the supply of management talent or funding it...
BioCentury | Oct 17, 2016
Financial News

UGISense completes venture financing

UGISense AG , Munich, Germany Business: Genomics Date completed: 2016-10-12 Type: Venture financing Raised: EUR1.2 million ($1.3 million) Investors: Lead Discovery Center GmbH ; private investors WIR Staff...
Items per page:
1 - 2 of 2